SHSE:688606 (China)
Â
Class A
Â¥
43.76
-1.17 (-2.6%)
Sep 11
Business Description
Hangzhou Alltest Biotech Co Ltd
ISIN : CNE1000053G6
Share Class Description:
SHSE:688606: Class ATotal Employee Number:
992Compare
Compare
Traded in other countries / regions
688606.China Index Membership
SSE Composite Index IPO Date
2021-03-25Description
Hangzhou Alltest Biotech Co Ltd is engaged in the research and development, production and sales of in vitro diagnostic reagents.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 302.07 | |||||
Equity-to-Asset | 0.94 | |||||
Debt-to-EBITDA | 0.05 | |||||
Interest Coverage | 425.36 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 10.09 | |||||
Beneish M-Score | -2.39 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -35.6 | |||||
3-Year EBITDA Growth Rate | -41.2 | |||||
3-Year EPS without NRI Growth Rate | -48.6 | |||||
3-Year Book Growth Rate | -1.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 15.31 | |||||
9-Day RSI | 26.76 | |||||
14-Day RSI | 35.49 | |||||
3-1 Month Momentum % | 6.42 | |||||
6-1 Month Momentum % | -25.64 | |||||
12-1 Month Momentum % | -26.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 11.2 | |||||
Quick Ratio | 10.36 | |||||
Cash Ratio | 9.26 | |||||
Days Inventory | 149.26 | |||||
Days Sales Outstanding | 65.12 | |||||
Days Payable | 67.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 4.45 | |||||
Dividend Payout Ratio | 1.47 | |||||
3-Year Dividend Growth Rate | -2.6 | |||||
Forward Dividend Yield % | 4.45 | |||||
5-Year Yield-on-Cost % | 4.46 | |||||
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | 4.38 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 49.16 | |||||
Operating Margin % | 17.7 | |||||
Net Margin % | 16.02 | |||||
EBITDA Margin % | 17.69 | |||||
FCF Margin % | 6.58 | |||||
OCF Margin % | 22.83 | |||||
ROE % | 3.58 | |||||
ROA % | 3.35 | |||||
ROIC % | 8.62 | |||||
3-Year ROIIC % | -128.97 | |||||
ROC (Joel Greenblatt) % | 13.12 | |||||
ROCE % | 3.95 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 25.01 | |||||
Forward PE Ratio | 5.48 | |||||
PE Ratio without NRI | 32.22 | |||||
Shiller PE Ratio | 8.7 | |||||
PS Ratio | 4 | |||||
PB Ratio | 0.92 | |||||
Price-to-Tangible-Book | 0.96 | |||||
Price-to-Free-Cash-Flow | 58.5 | |||||
Price-to-Operating-Cash-Flow | 17.32 | |||||
EV-to-EBIT | 8.35 | |||||
EV-to-EBITDA | 8.35 | |||||
EV-to-Revenue | 1.48 | |||||
EV-to-FCF | 22.43 | |||||
Price-to-GF-Value | 0.52 | |||||
Price-to-Projected-FCF | 0.58 | |||||
Price-to-Graham-Number | 1.17 | |||||
| Price-to-Net-Current-Asset-Value | 1.49 | |||||
| Price-to-Net-Cash | 1.84 | |||||
Earnings Yield (Greenblatt) % | 11.98 | |||||
FCF Yield % | 1.73 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hangzhou Alltest Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 867.639 | ||
| EPS (TTM) (Â¥) | 1.75 | ||
| Beta | 0.9679 | ||
| 3-Year Sharpe Ratio | 0.04 | ||
| 3-Year Sortino Ratio | 0.07 | ||
| Volatility % | 26.9 | ||
| 14-Day RSI | 35.49 | ||
| 14-Day ATR (Â¥) | 1.245547 | ||
| 20-Day SMA (Â¥) | 46.92 | ||
| 12-1 Month Momentum % | -26.99 | ||
| 52-Week Range (Â¥) | 39.8 - 72.88 | ||
| Shares Outstanding (Mil) | 75.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hangzhou Alltest Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hangzhou Alltest Biotech Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 1.000000 Cash Dividend | 2026-06-01 | 47.45 (-2.57%) | ||
| CNY 1.000000 Cash Dividend | 2025-10-16 | 68.15 (+1.56%) | ||
| CNY 1.500000 Cash Dividend | 2025-06-11 | 68.33 (-0.19%) | ||
| CNY 1.500000 Cash Dividend | 2024-10-25 | 69.92 (+0.13%) | ||
| 1.48:1 Stock Split | 2023-06-09 | 69.83 (+2.99%) |
Show
Entries
Hangzhou Alltest Biotech Co Ltd Frequently Asked Questions
What is Hangzhou Alltest Biotech Co Ltd(SHSE:688606)'s stock price today?
The current price of SHSE:688606 is ¥43.76. The 52 week high of SHSE:688606 is ¥72.88 and 52 week low is ¥39.80.
When is next earnings date of Hangzhou Alltest Biotech Co Ltd(SHSE:688606)?
The next earnings date of Hangzhou Alltest Biotech Co Ltd(SHSE:688606) is .
Does Hangzhou Alltest Biotech Co Ltd(SHSE:688606) pay dividends? If so, how much?
The Dividend Yield %  of Hangzhou Alltest Biotech Co Ltd(SHSE:688606) is 4.45% (As of Today), Highest Dividend Payout Ratio of Hangzhou Alltest Biotech Co Ltd(SHSE:688606) was 3.65. The lowest was 0.13. And the median was 1. The  Forward Dividend Yield % of Hangzhou Alltest Biotech Co Ltd(SHSE:688606) is 4.45%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers